Skip to main content
. 2021 Dec 28;82:105900. doi: 10.1016/j.ultsonch.2021.105900

Fig. 7.

Fig. 7

Antiproliferative properties of the nanoencapsulated HT against (a) adenocarcinomic human alveolar epithelial cells (A549) and (b) human breast cancer cells (MDA-MB-231).